Study details
Enrolling now
Nectero EAST System Clinical Trial
Nectero Medical, Inc.
NCT IDNCT06001918ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2/3
Target enrollment
400
Study length
about 6.2 years
Ages
21–85
Locations
37 sites in AZ, CO, DC +23
What this study is about
This trial is testing a treatment called the Nectero EAST System for patients with small to mid-sized abdominal aortic aneurysms. The goal is to see if this treatment stabilizes these aneurysms and compare it to standard care, which is surveillance.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Nectero EAST System
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Primary Endpoint